Business · 02/04/2019
FDA Clears ONFI (Clobazam) Tablets for Approval
The FDA has ruled that the 5mg version of ONFI tablets, a medication by Novartis, was not removed from the market due to safety or efficacy concerns, paving the way for potential approval of generic versions.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →